P38 MAP kinase inhibitors and methods for using the same

Details for Australian Patent Application No. 2006283941 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gabriel, Tobias; Billedeau, Roland J.; Dewdney, Nolan James

Agent Davies Collison Cave

Pub. Number AU-A-2006283941

PCT Pub. Number WO2007/023111

Priority 60/712,010 25.08.05 US

Filing date 16 August 2006

Wipo publication date 1 March 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/023111 Priority application(s): WO2007/023111

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283944-P38 MAP kinase inhibitors and methods for using the same

2006283940-P38 MAP kinase inhibitors and methods for using the same